Table 2.
Residual tumor rate after VABB as a minimally invasive surgery for breast cancer.
| Residual tumor No. (%) | No residual tumor No. (%) | Residual tumor rate (%) | |
|---|---|---|---|
| Total | 79 | 47 | 62.7 |
| BI-RADS classification | |||
| 3 | 63(79.7) | 38(80.9) | 62.4 |
| 4a | 16(20.3) | 9(19.1) | 64.0 |
| Largest tumor dimension/mm | |||
| ≤10 | 11(13.9) | 9(19.2) | 55.0 |
| 10-20 | 51(64.6) | 23(48.9) | 68.9 |
| >20 | 17(21.5) | 15(31.9) | 53.1 |
| Histological type | |||
| IDC | 58(73.4) | 25(53.2) | 69.9 |
| DCIS | 11(13.9) | 15(31.9) | 42.3 |
| Others b | 10(12.7) | 7(14.9) | 58.8 |
| Lymph node status | |||
| LN- a | 61(77.2) | 43(91.5) | 58.7 |
| LN+ b | 18(22.8) | 4(8.5) | 81.8 |
a No metastatic axillary lymph node.b One or more metastatic axillary lymph node.